VVZ API is not affiliated with ETH Zurich. Data might be outdated or incorrect. Please view the official ETHZ Vorlesungsverzeichnis for binding information.
Immunology II
Last Updated: 2026-02-05 16:08:10
Abstract
Introduction into the cellular and molecular basis of the immune system and immune responses against diverse pathogens, tumors, transplants, and self (autoimmunity)
Objective
The lectures will provide a detailed understanding: - how innate and adaptive immune responses interact at the cellular and molecular level. - how the immune system recognizes and fights against pathogenic microorganisms including viruses, bacteria, and parasites. - why lymphocytes tolerate self molecules. - about function and dysfunction the intestinal immune system. - immunopathology and inflammatory diseases.
Content
The aim of lecture is to understand: > How pathogens are recognized by the innate immune system > Immune defense against various pathogens > Immunology of the skin, lung and intestines > Tumor immunology > Migration and homing of immune cells > tolerance and autoimmunity > T cell memory
Resources
Lecture Notes
Presentations of the lecturers are available at the Moodle link
Literature
Recommended: Kuby Immunology (Freeman)
General Information
- Language
- English
- Levels
- BSC , MSC
- Frequency
- Yearly recurring
Examination
- Type
- session examination
- Mode
- written 120 minutes
- Aids
- Keine.
- Digital
- The exam takes place on devices provided by ETH Zurich.
Course Components
| Type | Title | Time & Place | Hours |
|---|---|---|---|
| lecture | Immunology II |
|
2 h weekly |
Offered In
-
-
-
-
-
-
-
-
-
Elective Compulsory Concept Courses (See D-BIOL Master Studies Guide)
-
-
-
-
-
Computational Biology and Bioinformatics Master (More informations at: )
-
Advanced Courses (A total of 30 ECTS needs to be acquired in the Advanced Courses category. Thereof at least 16 ECTS in the Theory and 10 ECTS in the Biology category. Note that some of the lectures are being recorded: )
-
Biology (At least 10 ECTS need to be acquired in this category.)
-
-
-
-
-
-